News
06-06-2011, 11:40 PM
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
More... (http://www.news-medical.net/news/20110607/APP-to-commence-marketing-Letrozole-Tablets-for-breast-cancer-in-the-US.aspx)
More... (http://www.news-medical.net/news/20110607/APP-to-commence-marketing-Letrozole-Tablets-for-breast-cancer-in-the-US.aspx)